SlideShare a Scribd company logo
1 of 60
ACUTE KIDNEY
INJURY IN CHILDREN
Dr. Raghav Kakar
M.D. Paediatrics
Acute Kidney Injury (AKI): Definition
Formerly referred to as acute renal failure (ARF).
Defined as an “sudden deterioration in kidney function
results in the inability to maintain fluid and electrolyte
homeostasis”
Kidney function is dependent on
 Adequacy of blood supply to the kidney
– Prerenal
 Integrity of renal parenchyma
– Renal
 Patency of urinary tract
– Post renal
Epidemiology
 The incidence of AKI varies in different regions of
the world.
 Estimates range from 20 cases per year per
1,00,000 population in neonates to as low as 2
cases per year per 1,00,000 population in older
children
 The co-existence of AKI with critical illness occurs
at a rate of 10% and has 50% mortality in children
requiring dialysis.
ETIOLOGY
 Pre renal
 Intrinsic or renal
 Post renal
Pre Renal AKI
 Also called prerenal azotemia, is characterized by
diminished effective circulating arterial volume, which
leads to inadequate renal perfusion and a decreased
GFR .
 The kidneys are intrinsically normal, and prerenal failure
is reversible once the blood volume and hemodynamic
conditions are restored to normal.
Causes of PreRenal Azotemia
 Decreased true intravascular volume
 Acute gastroenteritis, Burns, Hemorrhage, Sepsis
 Decreased effective intravascular volume
 Burns, Nephrotic syndrome, Massive ascites, Anaphylaxis, Cardiac
failure, Shock
 Medications
 NSAIDs ,ACE inhibitors, ARBs
Renal (Intrinsic)
CAUSES –
1. Obstruction of renal artery or veins –
Renal vein thrombosis, Renal arterial obstruction,
2. Involvement of renal microvasculature –
HUS, HSP, Poly-arteritis, Collagen vascular disease
3. Glomerular causes-
PSGN, Crescentic GN
4. Interstitial causes-
Acute tubulointerstitial nephritis
5. Tubular causes (ATN)
Prolongation of pre-renal insult, intravascular hemolysis, sepsis,
nephrotoxic agents, multiorgan failure, rhabdomyolysis, snakebite,
falciparum malaria.
1. OBSTRUCTION OF RENAL ARTERIES AND
VEINS
 Bilateral renal arterial thrombosis may occur after
umbilical artery catheterisation in neonates
 Renal vein thrombosis may be a complication of IDM
especially following dehydration.
 In older children, renal vein thrombosis may occur
with nephrotic syndrome with anasarca and
dehydration.
 Gross haematuria, enlargement of kidneys and
azotemia are typical manifestation.
2. INVOLVEMENT OF RENAL
MICROVASCULATURE
 HUS is a common cause of AKI in chidren.
 Causes thrombotic microangiopathy
 2 types- D+HUS and D-HUS
 Common causes of D+HUS – EHEC(in developed countries),
Shigella dysentriae type I (in India)
 Following dysentery shigella-toxin enters the circulation and leads
to endothelial injury in microvasculature .
 Localized coagulation and deposition of platelet thrombi and fibrin
occurs in glomeruli causing decrease in GFR.
3. Glomerular disease
 PSGN,
 Post infectious GN,
 Cresentic GN,
 IgA nephropathy .
4. ACUTE INTERSTITIAL NEPHRITIS
 Usually occurs due to hypersensitivity reaction to some
drugs (ampicillin, cephalosporins, sulfonamides,
quinolones, NSAID’s, phenytoin etc)
 The patient may have fever , arthralgia , rash and
eosinophilia : urine often shows eosinophils
 Renal biopsy should be done if it is strongly suspected.
5. Acute Tubular Necrosis
 Characterized by renal tubular injury, may occur due to
ischaemia/hypoperfusion or due to injury froms drugs or
toxins.
 Ischaemic ATN is a continnum of physiologic responses
that is observed in prerenal azotemia.
 If the hypoperfusion is severe and prolonged, ATN can progress to
renal infarction and irreversible renal damage
 The course is subdivided into 4 phases :
 Initiation
 Extension
 Maintainance
 Recovery
(C) POST RENAL
 It includes a variety of disorders characterized by
obstruction of the urinary tract.
 In a patient with 2 functioning kidneys, obstruction must
be bilateral to result in AKI.
 Relief of the obstruction usually results in recovery of
renal function except in patients with associated renal
dysplasia or prolonged urinary tract obstruction.
Causes of post renal AKI
 Posterior urethral valves
 Ureteropelvic junction obstruction
 Ureterovesicular junction obstruction
 Ureterocele
 Tumor
 Urolithiasis
 Hemorrhagic cystitis
 Neurogenic bladder
CLINICAL EVALUATION
 Clinical features range from asymptomatic with
mild to moderate elevation in S.creatinine to
anuric renal failure
 Decrease or no urine output
 Fluid overload
 Hypertension
 Uraemia, dyselectrolytemia
HISTORY
 H/o blood loss, diarrhea, vomitting – prerenal aki.
 Past h/o pharyngitis with gross hematuria, edema,
hypertension – acute PSGN.
 Dysentery, petechiae, pallor- HUS.
 Sudden passage of dark red urine, pallor and jaundice
with h/o drug exposure – acute intravascular hemolysis
(G6PD def.).
 Rash with arthritis – SLE or HSP.
 H/o prolonged hypotension or exposure to nephrotoxic
drugs – ATN.
 H/o poor urinary stream with palpable UB or kidney –
obstructive uropathy.
 Abdominal colic, haematuria, dysuria – urinary tract
stones.
PHYSICAL EXAMINATION
Obtaining a thorough physical examination is extremely
important . Clues may be found in any of the following –
 Skin
 Eyes
 Ears
 Respiratory system
 Cardiovascular system
 Abdomen
Skin :-
 Palpable purpura - Systemic vasculitis
 Maculopapular rash - Allergic interstitial nephritis
Eye :-
 Uveitis – interstitial nephritis and necrotizing
vasculitis.
Ear :-
 Hearing loss - Alport disease and aminoglycoside
toxicity
 Mucosal or cartilaginous ulcerations – Wegener’s
granulomatosis
Respiratory system :-
 rapid and deep breathing – met. Acidosis
 basal crepts - volume overload
Cardiovascular examination :
 Pericardial friction rub - Uremic pericarditis
 Increased JVP, Gallop rhythm, pitting edema – CHF
due to volume overload.
Abdomen :
 Renal angle tenderness – nephrolithiasis, renal artery or
vein
thrombosis.
 Distended bladder – urinary obstruction.
 F/s/o chronic liver disease with ascites with prerenal AKI
– hepatorenal syndrome
Classification System
pRIFLE and AKIN grading
KDIGO Staging
DIAGNOSIS
LAB INVESIGATIONS
 Urine R/M
 CBC
 24 hour urinary protein
 Blood urea and S.
creatinine level
 Serum electrolytes
 Urine
 ASO titer
 C3 level
 Serum calcium
 Serum phosphate
 Serum uric acid
 ANA
 ABG
Urinanalysis
Pre-Renal Renal
Urinary sodium (mEq/l) < 20 > 40
Urinary osmolality (mOsm/kg) > 500 < 350
Blood urea to creatinine ratio >20:1 < 20:1
Fractional excretion of sodium < 1 > 1
Specific gravity >1.020 <1.010
Imaging
 Ultrasound of KUB - evaluates renal size, able to detect
masses, obstruction, stones.
 X-ray Abdomen
 Renal Scintigraphy
 DTPA : the differential functions of each kidney can be
derived.
 DMSA : gives excellent images of cortex and useful to define
areas of inflammation
RENAL BIOPSY
Indicated in
 Patient in whom the etiology is not identified.
 Unremitting AKI lasting longer then 2-3 wks or
in assessing the extent of renal damage and
outcome.
 Suspected drug induced AKI in a patient
receiving therapy with a potentially nephrotoxic
drugs.
Biomarkers
Role of Biomarkers in AKI
 Early prediction and diagnosis of AKI
 Identify the primary location of injury
 Pinpoint the duration and severity
 Identify the etiology of AKI
 Monitor response to intervention and treatment
Serum Creatinine
 Serum creatinine alone is a poor indicator of renal
function
 It varies widely with age, gender, diet, muscle mass,
medications, and hydration status
 Up to 50% of kidney function may be lost before serum
creatinine even begins to rise
Promising AKI Biomarkers
 Neutrophil gelatinase-associated lipocalin (NGAL)
 Interleukin 18 (IL-18)
 Kidney injury molecule 1 (KIM-1)
 Atrial Natriuretric Peptide
 Cystatin-C
Renal Angina Index
 The renal angina index is a predictive tool, performed on
admission to the pediatric intensive care unit, and used
to assess the risk for subsequent severe AKI (≥ doubling
of serum creatinine) 72 h later (Day-3 AKI).
 The angina index is a composite of risk strata and
clinical signs of injury.
 It consists of 3 risk factors and 2 markers of renal injury,
which are assigned points. Score more than 8 predicts
severe AKI.
Management
Management Goals
A. Maintenance of electrolyte and fluid balance.
B. Avoidance of life-threatening complications.
C. Adequate nutritional support.
D. Treatment of the underlying cause.
Management: FLUIDS
 If no evidence of volume overload or cardiac failure :
Fluid challenge of IV NS , 20 mL/kg over 30 min
 No void within 2-4 hr points to intrinsic or postrenal ARF
 Vigorous fluid resuscitation may be needed in sepsis
 Diuretics if no void with adequate circulation.
 In absence of urine output, strict fluid restriction.
 Renal dose of dopamine (2-3 μg / kg / min)
Hyperkalemia
1. Severe hyperkalemia (>7.0 mEq/L):
 Electrocardiographic changes or peripheral muscle
weakness
 Can be life-threatening and requires immediate
attention.
2. Acute management includes administration of:
 IV calcium to stabilize the cardiac membrane; and/or
glucose/insulin infusion,
 Sodium bicarbonate or Glucose-Insulin infusion
(promotes extracellular K shift into the cells)
 Kayexalate (an anion exchange resin): removes excess
K from the body.
Acidosis
1. In children with AKI:
 impaired acid excretion
 increased acid production (shock and sepsis)
2. Sodium bicarbonate should only be administered with
life threatening acidosis or hyperkalemia.
3. HCO3 > 12 mEq/L and/or arterial pH greater than 7.2
do not require immediate intervention.
Hypertension
 Most often a result of hyper-reninemia or from
expansion of fluid volume.
 Most commonly seen with AGN and HUS
 Management :
 Salt and water restriction.
 Diuretic adminiistration
 Anti-Hypertensives
Hyponatremia
 Most commonly dilutional
 Management:
 Fluid restriction
 3% Hypertonic saline to symptomatic patients or sodium
less than 120 mEq/L
 mEq sodium required = 0.6 X weight(kg) X ( 125-serum
sodium in
mEq/L )
Hypocalcemia
 Primarily treated by lowering the serum phosphate
levels.
 Phosphate binders can be administered.
 IV calcium should be avoided
 Aluminium-based binders should also be avoided.
Nutrition
 Sodium, potassium and phosphorous should be
restricted.
 Protein intake should also be moderately decreased.
 Adequate calories are needed to promote recovery
 Renal replacement therapy if sufficient calories cannot
be achieved (patient with oliguria or anuria)
 Patients with inappropriate nutrition have poorer
prognosis.
Indications for dialysis in ARF
 Severe fluid overload unresponsive to management
 Persistent hyperkalemia
 Severe met.acidosis unresponsive to management.
 Neurologic symptoms (altered mental status, seizures)
 BUN >100-150 mg/dL (or lower if rapidly rising)
 Ca:PO4 imbalance, with hypocalcemic tetany.
 Nutritional support in a child with oliguria or anuria.
3 types of dialysis-
 a. intermittent haemodialysis (IHD)
 b. peritoneal dialysis(PD)
 c. CRRT.
a. Intermittent Haemodialysis:
 Preffered in patients with relatively stable
hemodynamic state.
 Highly efficient, 1 session completes in 3-4 hrs
 Can be done 3-7 times/week
 Complication : hypotension, bleeding, thrombosis.
b. Peritoneal Dialysis:
 Most commonly used in infants & neonates.
 For 1 session→1 cycle of 45-60 min needs to be
repeated for 2-4 times/day.
 The infused volume of the diasylate is 800-
1100ml/m2
 No need for anticoagulation , so ↓sed risk of
bleeding , may cause abdominal pain & peritonitis
c. CRRT:
 Continuous renal replacement therapy (CRRT) is
associated with reduced mortality.
 CRRT usually involves the removal and return of
blood through a single cannula placed in a large vein
(venovenous therapy); arteriovenous therapies are
seldom used.
 CRRT causes less haemodynamic instability, because
fluid removal is slower and there is time for fluid to re-
equilibrate between body compartments.
 Indications - hemodynamic instability, sepsis,
extensive trauma, MODS.
 Continuous removal of solutes ,fluid & electrolytes
 3 types:
 CVVH - based on convection
 CVVHD - based on diffusion
 CVVHDF - based on convection and
diffusion.
Outcomes
 Mortality rates from 30-50% have been reported from
developing countries.
 But the results have markedly improved at tertiary centers
with proper expertise and modern facilities.
 Outcome depend upon underlying cause.
 Prognosis is favourable in ATN from volume depletion,
intravascular hemolysis, acute interstial nephritis and drugs or
toxin related AKI especially when complicating factor are
absent .
 In cresentic GN, atypical HUS, and AKI associated with
sepsis, multi organ failure the prognosis is less satisfactory .
Take Home Message
 AKI is a common and serious problem
 All AKI are Not equal
 The diagnosis of AKI is often delayed.
 Earlier recognition and treatment of AKI sequelae may
improve outcome
 Novel biomarkers are providing tools for the early
prediction of AKI and outcomes, and for testing
therapies
Thank you

More Related Content

What's hot

Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndromeNajib Suhrabi
 
Urinary Tract Infections in children
 Urinary Tract Infections in children Urinary Tract Infections in children
Urinary Tract Infections in childrenAzad Haleem
 
Anaemia in children
Anaemia in childrenAnaemia in children
Anaemia in childrengiridharkv
 
Approach to a child with jaundice
Approach to a child with jaundice Approach to a child with jaundice
Approach to a child with jaundice Bala Sankar
 
Approach to the child with anemia
Approach to the child with anemiaApproach to the child with anemia
Approach to the child with anemiaEngidaw Ambelu
 
Pediatric hypertension
Pediatric hypertensionPediatric hypertension
Pediatric hypertensionTauhid Iqbali
 
Approach to a child with hematuria
Approach to a child with hematuriaApproach to a child with hematuria
Approach to a child with hematuriaSunil Agrawal
 
Chronic renal failure in children
Chronic renal failure in childrenChronic renal failure in children
Chronic renal failure in childrenVirendra Hindustani
 
Prematurity Pediatrics
Prematurity Pediatrics Prematurity Pediatrics
Prematurity Pediatrics NITISH SHAH
 
Diabetic keto acidosis in children ... Dr.Padmesh
Diabetic keto acidosis in children ...  Dr.PadmeshDiabetic keto acidosis in children ...  Dr.Padmesh
Diabetic keto acidosis in children ... Dr.PadmeshDr Padmesh Vadakepat
 
Neonatal thrombocytopenia
Neonatal thrombocytopeniaNeonatal thrombocytopenia
Neonatal thrombocytopeniaAjay Agade
 
Pediatric urinary tract infection
Pediatric urinary tract infectionPediatric urinary tract infection
Pediatric urinary tract infectionpediatricsmgmcri
 
Hemolytic anemia in children
Hemolytic anemia in childrenHemolytic anemia in children
Hemolytic anemia in childrenImran Iqbal
 
Nephrotic syndrome in children
Nephrotic syndrome in childrenNephrotic syndrome in children
Nephrotic syndrome in childrenShriyans Jain
 
Seizure Disorders in Children
Seizure Disorders in ChildrenSeizure Disorders in Children
Seizure Disorders in ChildrenCSN Vittal
 

What's hot (20)

Hemolytic uremic syndrome
Hemolytic uremic syndromeHemolytic uremic syndrome
Hemolytic uremic syndrome
 
Urinary Tract Infections in children
 Urinary Tract Infections in children Urinary Tract Infections in children
Urinary Tract Infections in children
 
Anaemia in children
Anaemia in childrenAnaemia in children
Anaemia in children
 
Prematurity
PrematurityPrematurity
Prematurity
 
Approach to a child with jaundice
Approach to a child with jaundice Approach to a child with jaundice
Approach to a child with jaundice
 
Approach to the child with anemia
Approach to the child with anemiaApproach to the child with anemia
Approach to the child with anemia
 
Pediatric hypertension
Pediatric hypertensionPediatric hypertension
Pediatric hypertension
 
Approach to a child with hematuria
Approach to a child with hematuriaApproach to a child with hematuria
Approach to a child with hematuria
 
Chronic renal failure in children
Chronic renal failure in childrenChronic renal failure in children
Chronic renal failure in children
 
Prematurity Pediatrics
Prematurity Pediatrics Prematurity Pediatrics
Prematurity Pediatrics
 
Diabetic keto acidosis in children ... Dr.Padmesh
Diabetic keto acidosis in children ...  Dr.PadmeshDiabetic keto acidosis in children ...  Dr.Padmesh
Diabetic keto acidosis in children ... Dr.Padmesh
 
Kawasaki disease
Kawasaki diseaseKawasaki disease
Kawasaki disease
 
approach to comatose child
approach to comatose childapproach to comatose child
approach to comatose child
 
Hematuria In Children
Hematuria In ChildrenHematuria In Children
Hematuria In Children
 
Neonatal thrombocytopenia
Neonatal thrombocytopeniaNeonatal thrombocytopenia
Neonatal thrombocytopenia
 
Pediatric urinary tract infection
Pediatric urinary tract infectionPediatric urinary tract infection
Pediatric urinary tract infection
 
Hemolytic anemia in children
Hemolytic anemia in childrenHemolytic anemia in children
Hemolytic anemia in children
 
Nephrotic syndrome in children
Nephrotic syndrome in childrenNephrotic syndrome in children
Nephrotic syndrome in children
 
Seizure Disorders in Children
Seizure Disorders in ChildrenSeizure Disorders in Children
Seizure Disorders in Children
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
 

Similar to Acute kidney injury in children 2018

Acute Kidney Failure in children.pptx
Acute  Kidney  Failure  in children.pptxAcute  Kidney  Failure  in children.pptx
Acute Kidney Failure in children.pptxzainjoiya3
 
Acute kidney injury and chronic kidney disease in children
Acute kidney injury and chronic kidney disease in childrenAcute kidney injury and chronic kidney disease in children
Acute kidney injury and chronic kidney disease in childrenSameekshya Pradhan
 
ACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
ACUTE KIDNEY INJURY / ACUTE RENAL FAILUREACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
ACUTE KIDNEY INJURY / ACUTE RENAL FAILUREDennis Daniel
 
Acute Kidney Injury
Acute Kidney InjuryAcute Kidney Injury
Acute Kidney InjuryViquas Saim
 
akifinal-140719124910-phpapp01-1.pdf
akifinal-140719124910-phpapp01-1.pdfakifinal-140719124910-phpapp01-1.pdf
akifinal-140719124910-phpapp01-1.pdfDereseBishaw
 
ACUTE KIDNEY INJURY.pptx
ACUTE KIDNEY INJURY.pptxACUTE KIDNEY INJURY.pptx
ACUTE KIDNEY INJURY.pptxAhmad Atere
 
Lec AKI.ppt
Lec AKI.pptLec AKI.ppt
Lec AKI.ppttesfkeb
 
Acute kidney injury in children.pptx
Acute kidney injury in children.pptxAcute kidney injury in children.pptx
Acute kidney injury in children.pptxSabonaLemessa2
 
Guideline, management of acute kidney injury
Guideline, management of acute kidney injuryGuideline, management of acute kidney injury
Guideline, management of acute kidney injuryvita madmo
 
Acute kidney injury in children
Acute kidney injury in childrenAcute kidney injury in children
Acute kidney injury in childrenIssam Abou Najab
 
Acute kidney injury defnition, causes,
Acute kidney injury   defnition, causes,Acute kidney injury   defnition, causes,
Acute kidney injury defnition, causes,PGIMER,DR.RML HOSPITAL
 
acute-kidney-injury.ppt
acute-kidney-injury.pptacute-kidney-injury.ppt
acute-kidney-injury.pptfatemehbemana1
 
ACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENTACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENTRajee Ravindran
 

Similar to Acute kidney injury in children 2018 (20)

Acute Kidney Failure in children.pptx
Acute  Kidney  Failure  in children.pptxAcute  Kidney  Failure  in children.pptx
Acute Kidney Failure in children.pptx
 
Acute kidney injury and chronic kidney disease in children
Acute kidney injury and chronic kidney disease in childrenAcute kidney injury and chronic kidney disease in children
Acute kidney injury and chronic kidney disease in children
 
ACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
ACUTE KIDNEY INJURY / ACUTE RENAL FAILUREACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
ACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
 
Acute Kidney Injury
Acute Kidney InjuryAcute Kidney Injury
Acute Kidney Injury
 
Acute Kidney Injury
Acute Kidney InjuryAcute Kidney Injury
Acute Kidney Injury
 
akifinal-140719124910-phpapp01-1.pdf
akifinal-140719124910-phpapp01-1.pdfakifinal-140719124910-phpapp01-1.pdf
akifinal-140719124910-phpapp01-1.pdf
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
AKI AND CKD
AKI AND CKDAKI AND CKD
AKI AND CKD
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
ACUTE KIDNEY INJURY.pptx
ACUTE KIDNEY INJURY.pptxACUTE KIDNEY INJURY.pptx
ACUTE KIDNEY INJURY.pptx
 
Lec AKI.ppt
Lec AKI.pptLec AKI.ppt
Lec AKI.ppt
 
Acute renal failure in icu
Acute renal failure in icuAcute renal failure in icu
Acute renal failure in icu
 
Acute kidney injury in children.pptx
Acute kidney injury in children.pptxAcute kidney injury in children.pptx
Acute kidney injury in children.pptx
 
Guideline, management of acute kidney injury
Guideline, management of acute kidney injuryGuideline, management of acute kidney injury
Guideline, management of acute kidney injury
 
Acute kidney injury in children
Acute kidney injury in childrenAcute kidney injury in children
Acute kidney injury in children
 
Acute kidney injury defnition, causes,
Acute kidney injury   defnition, causes,Acute kidney injury   defnition, causes,
Acute kidney injury defnition, causes,
 
acute-kidney-injury.ppt
acute-kidney-injury.pptacute-kidney-injury.ppt
acute-kidney-injury.ppt
 
ACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENTACUTE KIDNEY INJURY AND MANAGEMENT
ACUTE KIDNEY INJURY AND MANAGEMENT
 
Nephrology lectures
Nephrology lecturesNephrology lectures
Nephrology lectures
 
ACUTE KIDNEY INJURY.pptx
ACUTE KIDNEY INJURY.pptxACUTE KIDNEY INJURY.pptx
ACUTE KIDNEY INJURY.pptx
 

More from Raghav Kakar

history and examination in pediatric CVS
history and examination in pediatric CVShistory and examination in pediatric CVS
history and examination in pediatric CVSRaghav Kakar
 
Acute flaccid paralysis and Surveillance 2018
Acute flaccid paralysis and Surveillance 2018Acute flaccid paralysis and Surveillance 2018
Acute flaccid paralysis and Surveillance 2018Raghav Kakar
 
Allergic Disorders In Children
Allergic Disorders In ChildrenAllergic Disorders In Children
Allergic Disorders In ChildrenRaghav Kakar
 
Megaloblastic anaemia
Megaloblastic anaemiaMegaloblastic anaemia
Megaloblastic anaemiaRaghav Kakar
 
Approach to a case of paediatric hepatitis
Approach to a case of paediatric hepatitisApproach to a case of paediatric hepatitis
Approach to a case of paediatric hepatitisRaghav Kakar
 
An approach to a case of Paediatric Stridor
An approach to a case of Paediatric StridorAn approach to a case of Paediatric Stridor
An approach to a case of Paediatric StridorRaghav Kakar
 

More from Raghav Kakar (6)

history and examination in pediatric CVS
history and examination in pediatric CVShistory and examination in pediatric CVS
history and examination in pediatric CVS
 
Acute flaccid paralysis and Surveillance 2018
Acute flaccid paralysis and Surveillance 2018Acute flaccid paralysis and Surveillance 2018
Acute flaccid paralysis and Surveillance 2018
 
Allergic Disorders In Children
Allergic Disorders In ChildrenAllergic Disorders In Children
Allergic Disorders In Children
 
Megaloblastic anaemia
Megaloblastic anaemiaMegaloblastic anaemia
Megaloblastic anaemia
 
Approach to a case of paediatric hepatitis
Approach to a case of paediatric hepatitisApproach to a case of paediatric hepatitis
Approach to a case of paediatric hepatitis
 
An approach to a case of Paediatric Stridor
An approach to a case of Paediatric StridorAn approach to a case of Paediatric Stridor
An approach to a case of Paediatric Stridor
 

Recently uploaded

Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 

Recently uploaded (20)

Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 

Acute kidney injury in children 2018

  • 1. ACUTE KIDNEY INJURY IN CHILDREN Dr. Raghav Kakar M.D. Paediatrics
  • 2. Acute Kidney Injury (AKI): Definition Formerly referred to as acute renal failure (ARF). Defined as an “sudden deterioration in kidney function results in the inability to maintain fluid and electrolyte homeostasis”
  • 3. Kidney function is dependent on  Adequacy of blood supply to the kidney – Prerenal  Integrity of renal parenchyma – Renal  Patency of urinary tract – Post renal
  • 5.  The incidence of AKI varies in different regions of the world.  Estimates range from 20 cases per year per 1,00,000 population in neonates to as low as 2 cases per year per 1,00,000 population in older children  The co-existence of AKI with critical illness occurs at a rate of 10% and has 50% mortality in children requiring dialysis.
  • 7.  Pre renal  Intrinsic or renal  Post renal
  • 8. Pre Renal AKI  Also called prerenal azotemia, is characterized by diminished effective circulating arterial volume, which leads to inadequate renal perfusion and a decreased GFR .  The kidneys are intrinsically normal, and prerenal failure is reversible once the blood volume and hemodynamic conditions are restored to normal.
  • 9. Causes of PreRenal Azotemia  Decreased true intravascular volume  Acute gastroenteritis, Burns, Hemorrhage, Sepsis  Decreased effective intravascular volume  Burns, Nephrotic syndrome, Massive ascites, Anaphylaxis, Cardiac failure, Shock  Medications  NSAIDs ,ACE inhibitors, ARBs
  • 10. Renal (Intrinsic) CAUSES – 1. Obstruction of renal artery or veins – Renal vein thrombosis, Renal arterial obstruction, 2. Involvement of renal microvasculature – HUS, HSP, Poly-arteritis, Collagen vascular disease 3. Glomerular causes- PSGN, Crescentic GN 4. Interstitial causes- Acute tubulointerstitial nephritis 5. Tubular causes (ATN) Prolongation of pre-renal insult, intravascular hemolysis, sepsis, nephrotoxic agents, multiorgan failure, rhabdomyolysis, snakebite, falciparum malaria.
  • 11. 1. OBSTRUCTION OF RENAL ARTERIES AND VEINS  Bilateral renal arterial thrombosis may occur after umbilical artery catheterisation in neonates  Renal vein thrombosis may be a complication of IDM especially following dehydration.  In older children, renal vein thrombosis may occur with nephrotic syndrome with anasarca and dehydration.  Gross haematuria, enlargement of kidneys and azotemia are typical manifestation.
  • 12. 2. INVOLVEMENT OF RENAL MICROVASCULATURE  HUS is a common cause of AKI in chidren.  Causes thrombotic microangiopathy  2 types- D+HUS and D-HUS  Common causes of D+HUS – EHEC(in developed countries), Shigella dysentriae type I (in India)  Following dysentery shigella-toxin enters the circulation and leads to endothelial injury in microvasculature .  Localized coagulation and deposition of platelet thrombi and fibrin occurs in glomeruli causing decrease in GFR.
  • 13. 3. Glomerular disease  PSGN,  Post infectious GN,  Cresentic GN,  IgA nephropathy .
  • 14. 4. ACUTE INTERSTITIAL NEPHRITIS  Usually occurs due to hypersensitivity reaction to some drugs (ampicillin, cephalosporins, sulfonamides, quinolones, NSAID’s, phenytoin etc)  The patient may have fever , arthralgia , rash and eosinophilia : urine often shows eosinophils  Renal biopsy should be done if it is strongly suspected.
  • 15. 5. Acute Tubular Necrosis  Characterized by renal tubular injury, may occur due to ischaemia/hypoperfusion or due to injury froms drugs or toxins.  Ischaemic ATN is a continnum of physiologic responses that is observed in prerenal azotemia.  If the hypoperfusion is severe and prolonged, ATN can progress to renal infarction and irreversible renal damage
  • 16.  The course is subdivided into 4 phases :  Initiation  Extension  Maintainance  Recovery
  • 17. (C) POST RENAL  It includes a variety of disorders characterized by obstruction of the urinary tract.  In a patient with 2 functioning kidneys, obstruction must be bilateral to result in AKI.  Relief of the obstruction usually results in recovery of renal function except in patients with associated renal dysplasia or prolonged urinary tract obstruction.
  • 18. Causes of post renal AKI  Posterior urethral valves  Ureteropelvic junction obstruction  Ureterovesicular junction obstruction  Ureterocele  Tumor  Urolithiasis  Hemorrhagic cystitis  Neurogenic bladder
  • 20.  Clinical features range from asymptomatic with mild to moderate elevation in S.creatinine to anuric renal failure  Decrease or no urine output  Fluid overload  Hypertension  Uraemia, dyselectrolytemia
  • 21. HISTORY  H/o blood loss, diarrhea, vomitting – prerenal aki.  Past h/o pharyngitis with gross hematuria, edema, hypertension – acute PSGN.  Dysentery, petechiae, pallor- HUS.  Sudden passage of dark red urine, pallor and jaundice with h/o drug exposure – acute intravascular hemolysis (G6PD def.).  Rash with arthritis – SLE or HSP.
  • 22.  H/o prolonged hypotension or exposure to nephrotoxic drugs – ATN.  H/o poor urinary stream with palpable UB or kidney – obstructive uropathy.  Abdominal colic, haematuria, dysuria – urinary tract stones.
  • 23. PHYSICAL EXAMINATION Obtaining a thorough physical examination is extremely important . Clues may be found in any of the following –  Skin  Eyes  Ears  Respiratory system  Cardiovascular system  Abdomen
  • 24. Skin :-  Palpable purpura - Systemic vasculitis  Maculopapular rash - Allergic interstitial nephritis Eye :-  Uveitis – interstitial nephritis and necrotizing vasculitis. Ear :-  Hearing loss - Alport disease and aminoglycoside toxicity  Mucosal or cartilaginous ulcerations – Wegener’s granulomatosis
  • 25. Respiratory system :-  rapid and deep breathing – met. Acidosis  basal crepts - volume overload Cardiovascular examination :  Pericardial friction rub - Uremic pericarditis  Increased JVP, Gallop rhythm, pitting edema – CHF due to volume overload.
  • 26. Abdomen :  Renal angle tenderness – nephrolithiasis, renal artery or vein thrombosis.  Distended bladder – urinary obstruction.  F/s/o chronic liver disease with ascites with prerenal AKI – hepatorenal syndrome
  • 28. pRIFLE and AKIN grading
  • 31. LAB INVESIGATIONS  Urine R/M  CBC  24 hour urinary protein  Blood urea and S. creatinine level  Serum electrolytes  Urine  ASO titer  C3 level  Serum calcium  Serum phosphate  Serum uric acid  ANA  ABG
  • 32. Urinanalysis Pre-Renal Renal Urinary sodium (mEq/l) < 20 > 40 Urinary osmolality (mOsm/kg) > 500 < 350 Blood urea to creatinine ratio >20:1 < 20:1 Fractional excretion of sodium < 1 > 1 Specific gravity >1.020 <1.010
  • 33. Imaging  Ultrasound of KUB - evaluates renal size, able to detect masses, obstruction, stones.  X-ray Abdomen  Renal Scintigraphy  DTPA : the differential functions of each kidney can be derived.  DMSA : gives excellent images of cortex and useful to define areas of inflammation
  • 34. RENAL BIOPSY Indicated in  Patient in whom the etiology is not identified.  Unremitting AKI lasting longer then 2-3 wks or in assessing the extent of renal damage and outcome.  Suspected drug induced AKI in a patient receiving therapy with a potentially nephrotoxic drugs.
  • 36. Role of Biomarkers in AKI  Early prediction and diagnosis of AKI  Identify the primary location of injury  Pinpoint the duration and severity  Identify the etiology of AKI  Monitor response to intervention and treatment
  • 37. Serum Creatinine  Serum creatinine alone is a poor indicator of renal function  It varies widely with age, gender, diet, muscle mass, medications, and hydration status  Up to 50% of kidney function may be lost before serum creatinine even begins to rise
  • 38.
  • 39. Promising AKI Biomarkers  Neutrophil gelatinase-associated lipocalin (NGAL)  Interleukin 18 (IL-18)  Kidney injury molecule 1 (KIM-1)  Atrial Natriuretric Peptide  Cystatin-C
  • 40. Renal Angina Index  The renal angina index is a predictive tool, performed on admission to the pediatric intensive care unit, and used to assess the risk for subsequent severe AKI (≥ doubling of serum creatinine) 72 h later (Day-3 AKI).  The angina index is a composite of risk strata and clinical signs of injury.  It consists of 3 risk factors and 2 markers of renal injury, which are assigned points. Score more than 8 predicts severe AKI.
  • 41.
  • 43. Management Goals A. Maintenance of electrolyte and fluid balance. B. Avoidance of life-threatening complications. C. Adequate nutritional support. D. Treatment of the underlying cause.
  • 44. Management: FLUIDS  If no evidence of volume overload or cardiac failure : Fluid challenge of IV NS , 20 mL/kg over 30 min  No void within 2-4 hr points to intrinsic or postrenal ARF  Vigorous fluid resuscitation may be needed in sepsis  Diuretics if no void with adequate circulation.  In absence of urine output, strict fluid restriction.  Renal dose of dopamine (2-3 μg / kg / min)
  • 45. Hyperkalemia 1. Severe hyperkalemia (>7.0 mEq/L):  Electrocardiographic changes or peripheral muscle weakness  Can be life-threatening and requires immediate attention. 2. Acute management includes administration of:  IV calcium to stabilize the cardiac membrane; and/or glucose/insulin infusion,  Sodium bicarbonate or Glucose-Insulin infusion (promotes extracellular K shift into the cells)  Kayexalate (an anion exchange resin): removes excess K from the body.
  • 46. Acidosis 1. In children with AKI:  impaired acid excretion  increased acid production (shock and sepsis) 2. Sodium bicarbonate should only be administered with life threatening acidosis or hyperkalemia. 3. HCO3 > 12 mEq/L and/or arterial pH greater than 7.2 do not require immediate intervention.
  • 47. Hypertension  Most often a result of hyper-reninemia or from expansion of fluid volume.  Most commonly seen with AGN and HUS  Management :  Salt and water restriction.  Diuretic adminiistration  Anti-Hypertensives
  • 48. Hyponatremia  Most commonly dilutional  Management:  Fluid restriction  3% Hypertonic saline to symptomatic patients or sodium less than 120 mEq/L  mEq sodium required = 0.6 X weight(kg) X ( 125-serum sodium in mEq/L )
  • 49. Hypocalcemia  Primarily treated by lowering the serum phosphate levels.  Phosphate binders can be administered.  IV calcium should be avoided  Aluminium-based binders should also be avoided.
  • 50. Nutrition  Sodium, potassium and phosphorous should be restricted.  Protein intake should also be moderately decreased.  Adequate calories are needed to promote recovery  Renal replacement therapy if sufficient calories cannot be achieved (patient with oliguria or anuria)  Patients with inappropriate nutrition have poorer prognosis.
  • 51. Indications for dialysis in ARF  Severe fluid overload unresponsive to management  Persistent hyperkalemia  Severe met.acidosis unresponsive to management.  Neurologic symptoms (altered mental status, seizures)  BUN >100-150 mg/dL (or lower if rapidly rising)  Ca:PO4 imbalance, with hypocalcemic tetany.  Nutritional support in a child with oliguria or anuria.
  • 52. 3 types of dialysis-  a. intermittent haemodialysis (IHD)  b. peritoneal dialysis(PD)  c. CRRT. a. Intermittent Haemodialysis:  Preffered in patients with relatively stable hemodynamic state.  Highly efficient, 1 session completes in 3-4 hrs  Can be done 3-7 times/week  Complication : hypotension, bleeding, thrombosis.
  • 53.
  • 54. b. Peritoneal Dialysis:  Most commonly used in infants & neonates.  For 1 session→1 cycle of 45-60 min needs to be repeated for 2-4 times/day.  The infused volume of the diasylate is 800- 1100ml/m2  No need for anticoagulation , so ↓sed risk of bleeding , may cause abdominal pain & peritonitis
  • 55. c. CRRT:  Continuous renal replacement therapy (CRRT) is associated with reduced mortality.  CRRT usually involves the removal and return of blood through a single cannula placed in a large vein (venovenous therapy); arteriovenous therapies are seldom used.  CRRT causes less haemodynamic instability, because fluid removal is slower and there is time for fluid to re- equilibrate between body compartments.
  • 56.  Indications - hemodynamic instability, sepsis, extensive trauma, MODS.  Continuous removal of solutes ,fluid & electrolytes  3 types:  CVVH - based on convection  CVVHD - based on diffusion  CVVHDF - based on convection and diffusion.
  • 57.
  • 58. Outcomes  Mortality rates from 30-50% have been reported from developing countries.  But the results have markedly improved at tertiary centers with proper expertise and modern facilities.  Outcome depend upon underlying cause.  Prognosis is favourable in ATN from volume depletion, intravascular hemolysis, acute interstial nephritis and drugs or toxin related AKI especially when complicating factor are absent .  In cresentic GN, atypical HUS, and AKI associated with sepsis, multi organ failure the prognosis is less satisfactory .
  • 59. Take Home Message  AKI is a common and serious problem  All AKI are Not equal  The diagnosis of AKI is often delayed.  Earlier recognition and treatment of AKI sequelae may improve outcome  Novel biomarkers are providing tools for the early prediction of AKI and outcomes, and for testing therapies

Editor's Notes

  1. Sudden = 48 hours to 7 days....sudden and sustained decline in GFR
  2. HEPATORENAL SYNDROME Most common causes in our country are...volume loss...HUS....and Infections In critical care settings, AKI is most commonly caused bby secondary renal injury---ACUTE TUBULAR NECROSIS
  3. Nephrotoxic agents : Aminoglycosides, NSAIDs, Tacrolimus, Cyclosporine
  4. Shigella toxin targets GB3 cells present in endothelium of heart brain kidney liver etc. Typical and atypical type.
  5. Endogenous toxins: Hb release– Malaria, G6PD, Snake bite, Rh incompatibility Exogenous Toxins : Drugs that impair autoregulation: Cyclosporine, Tacrolimus, NSAIDs, ACE inhibitors
  6. The initiation phase --- primary insult resulting in drop in GFR and tubular dysfunction Maintainance phase --- oligoanuria. The recovery phase ---restoration of GFR and Tubular functions and manifests with polyuria initially, after which the urine output returns to normal
  7. Gfr= k X ht / S.creatinine.........V x U / p ---- urine creatinine x blood flow / s. cratinine
  8. Kidney Disease Improvement global outcome
  9. Dmsa dimercapto succinic acid Dpta diethylene triamine pents acetic acid.—glomerular filtration agent
  10. NGAL is a Low Molecular Weight Tubular Protein
  11. FO = [(Fluid IN – Fluid OUT (L)) / (Admit weight in kilograms)] * 100 SCORE MORE THAN 8 PREDICTS POOR OUTCOME
  12. 400ml/m2/day + urine output + extra body fluid losses
  13. Sodiyn Polysterene sulphate resin—Kayexelite---exchanges potassium with sodium---can lead to Hypernatremia
  14. Isradipine....beta blockers....calcium channel blockers..... In hypertensive emergencies...nicardipine, sodium nitroprusside
  15. Lethargy seizures
  16. Calcium carbonate...calcium oxalate... Avoided for tetany
  17. High sodium :: ............, Low sodium......... High potassium::...........low pottasium........ High phosphorous::...........low phosphorous::.......
  18. Haemodialysis :Used to remove nitrogenous wastes from the body The dialysis machine contains a number of tubes with semi permeable lining, suspended in a tank filled with dialysing fluid This fluid has the same osmotic pressure as blood,except that it lacks nitrogenous wastes. One line connected to the artey is connected to the one end of dialysis device where blood is collected from patient for filtration During this passage,the waste products from the blood pass into the dialysing fluid by diffusion. The purified blood is pumped into the vein of the patient which is connected to the other end of the dialysis device. this is similar to the function of the kidney but it is different in the way that no reabsorption is involved. Normally,in a healthy adult,the intake filtrate in the kidneys is 180 litres. However,the volume is actually only a litre or two a day because the remaining filtrate is reabsorbed in the kidney tubules.
  19. In the dialyser are thousands of fine fibre tubes that mimic the body's own glomeruli and filter the blood as it flows through them. They are semi-permeable and allow the small molecules of fluids and soluble wastes to move through tiny holes in the membrane into the surrounding canister which is continuously flushed with dialysis fluid.
  20. peritoneal dialysis uses the peritoneum as the filter. A tube called the catheteres (tenckhoff) surgically placed through the wall of the abdomen. About 3-4 inches is left outside. A special solution Hypertonic diasylate flows from the catheter into the peritoneal cavity. As the solution remains in the peritoneal cavity,waste products and excess fluid pass from the blood through the peritoneal membrane into the filtering device. After a certain number of hours,solution is drained out of the peritoneal cavity.
  21. Small molecule removed by convection diffusion Middle: convection Large: convection Extra large: minimal by crrt
  22. CVVH :Continuous Veno Venous Haemofiltration CVVHD : Continuous venovenous hemo-dialysis CAVHDF: veno venous hemodiafiltration